Stockreport

XORTX Announces Presentation at the Rare and Genetic Disease Summit

XORTX Therapeutics Inc.  (XRTX) 
PDF CALGARY, Alberta, Dec. 12, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clini [Read more]